PHA-793887

N/A

Report date: 2026/01/06 18:01:03
NME

Base Information

Drug NamePHA-793887
Drug Alias NamePHA-793887
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 4 inhibitorsCyclin-dependent kinase 2 inhibitorsCyclin-dependent kinase 1 inhibitors +[5] 
TargetsCyclin-dependent kinase 4Cyclin-dependent kinase 2Cyclin-dependent kinase 1 +[5] 
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomFrance
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNerviano Medical Sciences Srl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNerviano Medical Sciences Srl
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A